EN DE
Watch TELES Informationstechnologien AG for free: once a week we email you where price and fair value stand.
Data-driven stock valuation

TELES Informationstechnologien AG (TLIK) fair value: what the stock is really worth

As of Nov 16, 2026: fair value (intrinsic value) of TELES Informationstechnologien AG stock €0.12, price €0.28, that is 56.8% below the price, quality 31 out of 100. Rating: strongly overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare DE · ISIN DE000A289B07

TI TELES Informationstechnologien AG logo Thin data Nov 10, 2026

TELES Informationstechnologien AG

TLIK · XETRA

Far too expensive (fair value 57% below the price), weak company and falling price: meets none of the 3 rules.

Follow free in the weekly email
Mixed Growth (revenue 3y −36.1 %/yr in EUR) 
Negative equity (buybacks among others) 
Fair value €0.1209 · Strongly overvalued 
Quality 31/100 
Falling price (downtrend) 
Loss-making · -127.0% net margin (FY2024) 
Negative free cash flow 
Trails peers (1/6) 
Narrow moat 6/100 · thin data
Thin data 
Estimate⚠ Thinly traded
Watch TELES Informationstechnologien AG for free: once a week we email you where price and fair value stand. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

€8.95 €0.1000 Fair Value €0.1209 Apr 2018 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 10, 2026.

How to read this chart

60‑month range €0.1000 – €8.95 · fair‑value band €0.0907 – €0.1511 · the €0.2800 price screens above the €0.1209 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. As of Nov 10, 2026.

Follow TELES Informationstechnologien in your weekly email

Every Wednesday you see whether TELES Informationstechnologien is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Arzneiwerk AG VIDA engages in the supply of pharmaceuticals for newly developed or rare medicines in Europe. The company was formerly known as TELES Aktiengesellschaft and changed its name to Arzneiwerk AG VIDA in July 2024. The company was incorporated in 1996 and is based in Berlin, Germany.

Stock analysis

TELES Informationstechnologien AG (TLIK) currently trades at €0.2800, while our estimate is €0.1209, 57% below the price, so the stock looks overvalued today.

Show more

Valuation

None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Scenario range: €0.0907 (bear) to €0.1511 (bull), the price of €0.2800 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 31/100 (below-average quality), in the Healthcare sector.

Mixed Growth: Spin-off in 2021: revenue and profit before it include the divested business. Growth is measured afresh from 2021.

TELES Informationstechnologien AG reported revenue of €658K in FY2024 versus €2.8M in FY2020, a compound −30.5%/yr. Reported net income was −€835K in FY2024.

Key figures

Market cap €3.8M Micro · P/S ratio 15.9 · EPS (TTM) €−0.1300 · Net margin −127% · Return on equity −96.8% · Return on assets (EBIT) −24.2% (5-year average) · Operating margin −284% · Revenue (TTM) €239K.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 6 out of 100 (low confidence).

What moves the price

The share trades about 48% below its 52-week high and 180% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at 35% fair-value upside, at −57%, TLIK screens richer than that median.

Fair Value

Bear €0.0907 Fair Value €0.1209 Bull €0.1511
Price €0.2800 · Downside -56.8%
Estimate. None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Quality Score breakdown

Overall quality 31/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 7
How much profit the company makes from its sales and capital
Quality Growth 39
Are margins and returns getting better?
Cashflow 26
Do the profits arrive as real cash?
Financial strength 3
Debt, balance sheet and risk of trouble
Investment 66
Does it invest with discipline instead of growing at any price?
Low Volatility 32
How calm the share price moves, does not count
Price momentum 26
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 14
Distance to the 52-week high, does not count
New shares 82
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 55/100
Spin-off in 2021: revenue and profit before it include the divested business. Growth is measured afresh from 2021.
Revenue growth 1 year
−98.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−36.1%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−25.2% (2018) → −91.6% (2024)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2024 is a loss year, no rate is defined from a loss
not computed

TLIK screens overvalued: fair value 57% below the price. Compare with McKesson Corporation →

Compare TELES Informationstechnologien AG with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Distribution · 81 stocks

Beats the industry median on 1/6 measures
Overall it trails its industry peers.
Valuation
Quality Score 31 · Bottom 25%
Fair Value upside −56.8% · Bottom 25%
Profitability
Return on equity (12 months) Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
Return on assets −20.0% · Bottom 25%
Net margin (12 months) −127.0% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) 384.3% · Top 25%
Balance sheet
Debt / equity Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.

Valuation Multiplesvs Medical Distribution median · lower = cheaper

P/B Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
P/S (12 months) 15.91× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 30
FUTURE (revenue growth)100 · sector 20
PAST (return on equity)0 · sector 23
HEALTH (low debt)0 · sector 96
DIVIDEND (yield)0 · sector 54

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Distribution stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Sinopharm Group 1099 HK$16.87 HK$50.61 +200% vs TLIK
Jointown Pharmaceutical Group 600998 ¥5.27 ¥11.56 +119% vs TLIK
Shanghai Pharmaceuticals Holding 601607 ¥16.54 ¥35.78 +116% vs TLIK
China National Medicines Corporation 600511 ¥28.87 ¥58.47 +103% vs TLIK
Guangzhou Baiyunshan Pharmaceutical Holdings 600332 ¥19.68 ¥26.64 +35% vs TLIK
Cencora, Inc COR $350.56 $341.58 −3% vs TLIK
Henry Schein, Inc HSIC $82.94 $78.69 −5% vs TLIK
McKesson Corporation MCK $1,092 $822.74 −25% vs TLIK
Galenica AG GALE CHF 90.30 CHF 61.79 −32% vs TLIK
Cardinal Health, Inc CAH $279.25 $163.14 −42% vs TLIK

Explore undervalued stocks

More undervalued Healthcare stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

TELES Informationstechnologien AG: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "TELES Informationstechnologien AG Fair Value". https://www.fairvalue-calculator.com/stock/TLIK

Frequently asked questions

Is TELES Informationstechnologien AG (TLIK) overvalued or undervalued?
As of Nov 10, 2026, our estimate of fair value is €0.1209 versus a price of €0.2800, about 57% lower (overvalued).
What is the fair value of TLIK?
Our estimate for TELES Informationstechnologien AG is €0.1209 (as of Nov 10, 2026), built from audited fundamentals. The current price: €0.2800.
What is the quality score of TLIK?
TELES Informationstechnologien AG has a Quality Score of 31/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for TELES Informationstechnologien AG (TLIK)?
Our calculated price target is the estimate of €0.1209 (as of Nov 10, 2026). Cautious scenario €0.0907, optimistic scenario €0.1511. It is an estimate from revenue and assets compared with similar companies, because none of our valuation models currently carries, not an analyst target.
What is the TELES Informationstechnologien AG stock forecast for 2026?
Our estimate puts fair value at €0.1209, about 57% lower versus a price of €0.2800 (overvalued). Cautious scenario €0.0907, optimistic scenario €0.1511. The calculation is refreshed regularly with new filings.
What is the revenue of TELES Informationstechnologien AG (TLIK)?
TELES Informationstechnologien AG reported trailing-twelve-month revenue of about €239K (latest available figure, as of Nov 10, 2026).
What is the intrinsic value of TELES Informationstechnologien AG (TLIK)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For TELES Informationstechnologien AG it is €0.1209 per share (as of Nov 10, 2026), against a price of €0.2800.
Is TELES Informationstechnologien AG stock overvalued or undervalued in 2026?
As of Nov 10, 2026, TLIK trades above its calculated fair value: price €0.2800, fair value €0.1209, a gap of about −57% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of TLIK?
No. The price is what the market pays today (€0.2800); the fair value is what the company's own numbers justify (€0.1209). For TELES Informationstechnologien AG the two are €0.1591 per share apart. That gap is exactly why we show both numbers side by side.
How much is TELES Informationstechnologien AG worth?
The market values TELES Informationstechnologien AG at about €3.8M (market capitalisation, as of Nov 10, 2026). Per share that is €0.2800; our models calculate a fair value of €0.1209 per share.
What do the bullish and bearish scenarios say about TLIK?
Our models span a range for TELES Informationstechnologien AG: cautious scenario €0.0907, base €0.1209, optimistic €0.1511 per share (as of Nov 10, 2026, price €0.2800). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of TELES Informationstechnologien AG (TLIK)?
Balance-sheet figures for TELES Informationstechnologien AG (as of Nov 10, 2026): negative equity, so no return on equity and no debt-to-equity ratio. They feed the Quality Score of 31/100, which measures business quality independently of the share price.
How far is TLIK from its 52-week high?
TELES Informationstechnologien AG trades at €0.2800, about 48% below its 52-week high of €0.5400 and 180% above the low of €0.1000 (as of Nov 16, 2026). Distance from the high says nothing about value: that is what the fair value of €0.1209 is for.
Which stocks are comparable to TELES Informationstechnologien AG?
From the same area (Healthcare) we also value McKesson Corporation, Cencora, Inc, Cardinal Health, Inc, Henry Schein, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is TELES Informationstechnologien AG stock attractive at the current price?
The data as of Nov 10, 2026: price €0.2800, calculated fair value €0.1209 (−57%), Quality Score 31/100. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
Is it still worth investing in stocks now?
The global stock market currently sits 12.3% above its aggregate fair value. TELES Informationstechnologien AG itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of TELES Informationstechnologien AG (TLIK)?
The closing price on Nov 16, 2026 was €0.2800. Our estimate is €0.1209, about 57% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with TELES Informationstechnologien AG right now?
The price sits above even our optimistic bull case (€0.1511). The favourable scenario is already priced in. Weak quality (31/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.

Key figures of TELES Informationstechnologien AG

How large is the market capitalisation of TELES Informationstechnologien AG (TLIK)?
The market capitalisation of TELES Informationstechnologien AG is €3.8M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of TELES Informationstechnologien AG (TLIK)?
The price-to-sales ratio of TELES Informationstechnologien AG is 15.9 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of TELES Informationstechnologien AG (TLIK)?
Earnings per share at TELES Informationstechnologien AG are €−0.1300. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of TELES Informationstechnologien AG (TLIK)?
The net margin of TELES Informationstechnologien AG is −127% (fiscal year 2024). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of TELES Informationstechnologien AG (TLIK)?
The return on equity (ROE) of TELES Informationstechnologien AG is −96.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of TELES Informationstechnologien AG (TLIK)?
On an EBIT basis the return on assets of TELES Informationstechnologien AG is −24.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of TELES Informationstechnologien AG (TLIK)?
The operating margin of TELES Informationstechnologien AG is −284% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at TELES Informationstechnologien AG (TLIK)?
Revenue at TELES Informationstechnologien AG is growing 384% versus a year earlier (3y avg −36.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at TELES Informationstechnologien AG (TLIK)?
Earnings per share at TELES Informationstechnologien AG are down 98.4% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does TELES Informationstechnologien AG (TLIK) generate?
The free cash flow of TELES Informationstechnologien AG is −€1.4M (fiscal year 2024). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does TELES Informationstechnologien AG (TLIK) carry?
The net debt of TELES Informationstechnologien AG is €510K (fiscal year 2024). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch TELES Informationstechnologien AG in the live analysis

One click puts TELES Informationstechnologien AG on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.